Skip to main content

Table 2 Factors of hemostasis and endothelial dysfunction in men with coronary atherosclerosis (M ± σ)

From: Association of some hemostasis and endothelial dysfunction factors with probability of presence of vulnerable atherosclerotic plaques in patients with coronary atherosclerosis

Factors of hemostasis and endothelial dysfunction in the blood

Men (n = 54) with stable plaques in the coronary arteries

Men (n = 63) with vulnerable plaques in the coronary arteries

p

Factor II, µg/ml

252.1 ± 50.9

260.1 ± 58.9

0.474

Factor VII, ng/ml

422.0 ± 147.5

590.1 ± 150.1*

0.016

Factor XII, µg/ml

84.8 ± 58.1

119.9 ± 55.2*

0.010

Antithrombin III, µg/ml

610.9 ± 165.5

600.4 ± 209.6

0.851

Homocystein, µmol/l

18.2 ± 5.2

18.4 ± 8.1

0.626

MCP-1, pg/ml

525.7 ± 188.8

956.8 ± 501.8*

0.015

Endothelin-1, pmol/l

0.8 ± 0.6

1.3 ± 0.6

0.844

ADMA, µmol/l

1.4 ± 0.5

1.4 ± 0.7

0.821

PAI-1, ng/ml

397.5 ± 129.3

399.8 ± 136.5

0.855

sVCAM-1, ng/ml

1017.6 ± 521.8

716.5 ± 345.6*

0.025

  1. *p<0.05